tag:blogger.com,1999:blog-7923005810906159036.post8472868806248995394..comments2024-03-27T12:49:05.975+00:00Comments on IP finance: Pay-for-delay: a new article and a couple of questionsAnne Fairpohttp://www.blogger.com/profile/02579190868405783459noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-7923005810906159036.post-18116033047096063142013-12-19T09:01:03.518+00:002013-12-19T09:01:03.518+00:00I know little about this area, but in response to ...I know little about this area, but in response to your question about why this is restricted to pharma patents, perhaps it's because individual patents in that sector can be very valuable (protecting sales of hundreds of millions of dollars annually) and pay-for-delay settlements will stop a party taking action to get the patent revoked. Other sectors will rarely have individual patents that are so valuable that it's worth buying off potential attackers of the patents.Anonymousnoreply@blogger.com